Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Pottier

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Proteomics. Clinical Applications|August 13, 2017
MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot StudyDeborah Alberts, Charles Pottier, Nicolas Smargiasso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2026
Future approaches to immune base biomarkersMatthieu Roulleaux Dugage, François-Xavier Danlos, Julien Vibert, et al.
Cellular and Molecular Life Sciences : CMLS|May 14, 2022
Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonizationLionel Gillot, Alizée Lebeau, Louis Baudin, et al.
Proteomics. Clinical Applications|August 11, 2018
Microproteomic Profiling of High-Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic MarkersCharles Pottier, Mark Kriegsmann, Deborah Alberts, et al.
Omics : a Journal of Integrative Biology|August 9, 2014
Tissue proteomics for the next decade? Towards a molecular dimension in histologyRémi Longuespée, Maximilien Fléron, Charles Pottier, et al.
Oncoimmunology|March 28, 2017
A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancerCédric Balsat, Silvia Blacher, Michael Herfs, et al.
Medcomm|June 15, 2026
Stearoyl-CoA Desaturase-1 Drives Tumor Growth by Interacting With Histone Deacetylase-2 and Deacetylating Nucleophosmin-1Coline Wery, Laetitia Montero-Ruiz, Eric Bonneil, et al.
Redox Biology|May 24, 2021
Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrenceGéraldine Luis, Adrien Godfroid, Shin Nishiumi, et al.
Cancer Communications (London, England)|January 13, 2025
Targeting ferroptosis resistance resensitizes metastatic HR<sup>+</sup>HER2<sup>-</sup> breast cancer cells to palbociclib-hormone therapyCharles Pottier, Laetitia Montero-Ruiz, Robin Jehay, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Proteomics. Clinical Applications|August 13, 2017
MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot StudyDeborah Alberts, Charles Pottier, Nicolas Smargiasso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 7, 2026
Future approaches to immune base biomarkersMatthieu Roulleaux Dugage, François-Xavier Danlos, Julien Vibert, et al.
Cellular and Molecular Life Sciences : CMLS|May 14, 2022
Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonizationLionel Gillot, Alizée Lebeau, Louis Baudin, et al.
Proteomics. Clinical Applications|August 11, 2018
Microproteomic Profiling of High-Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic MarkersCharles Pottier, Mark Kriegsmann, Deborah Alberts, et al.
Omics : a Journal of Integrative Biology|August 9, 2014
Tissue proteomics for the next decade? Towards a molecular dimension in histologyRémi Longuespée, Maximilien Fléron, Charles Pottier, et al.
Oncoimmunology|March 28, 2017
A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancerCédric Balsat, Silvia Blacher, Michael Herfs, et al.
Medcomm|June 15, 2026
Stearoyl-CoA Desaturase-1 Drives Tumor Growth by Interacting With Histone Deacetylase-2 and Deacetylating Nucleophosmin-1Coline Wery, Laetitia Montero-Ruiz, Eric Bonneil, et al.
Redox Biology|May 24, 2021
Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrenceGéraldine Luis, Adrien Godfroid, Shin Nishiumi, et al.
Cancer Communications (London, England)|January 13, 2025
Targeting ferroptosis resistance resensitizes metastatic HR<sup>+</sup>HER2<sup>-</sup> breast cancer cells to palbociclib-hormone therapyCharles Pottier, Laetitia Montero-Ruiz, Robin Jehay, et al.
Pageof 2